Mitchell Sinkler & Starr PA Has $840,000 Holdings in Intuitive Surgical, Inc. $ISRG

Mitchell Sinkler & Starr PA increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.8% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,546 shares of the medical equipment provider’s stock after buying an additional 125 shares during the period. Mitchell Sinkler & Starr PA’s holdings in Intuitive Surgical were worth $840,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Chilton Capital Management LLC raised its stake in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 43 shares during the last quarter. Elite Financial Inc. bought a new position in Intuitive Surgical during the first quarter worth $26,000. LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical during the first quarter worth $30,000. TD Capital Management LLC raised its stake in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the last quarter. Finally, 1248 Management LLC bought a new position in Intuitive Surgical during the first quarter worth $30,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director owned 1,074 shares in the company, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on ISRG shares. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Piper Sandler reaffirmed an “overweight” rating and issued a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Finally, The Goldman Sachs Group decreased their price target on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research note on Wednesday, October 1st. Fourteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $589.43.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $429.59 on Friday. The stock has a market capitalization of $154.00 billion, a P/E ratio of 59.91, a P/E/G ratio of 4.51 and a beta of 1.61. The company has a 50-day moving average price of $458.68 and a 200-day moving average price of $497.91. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s revenue was up 21.4% on a year-over-year basis. During the same period last year, the company earned $1.78 earnings per share. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.